Advanced Radiation Therapy acquires AccuBoost assets

Advanced Radiation Therapy (ART), manufacturer of the AccuBoost System for partial breast irradiation, and Elekta have executed an agreement whereby ART acquires the assets of all AccuBoost installations held by Elekta, its worldwide distribution partner.

As part of the transaction, ART has purchased the assets and the operating agreements for more than 20 installations in the U.S.

The AccuBoost procedure is designed for women diagnosed with early stage breast cancer who pursue breast-conserving therapy (BCT). AccuBoost is a brachytherapy modality that uses image guidance to target the radiation dose for patients who choose BCT. The mammography image-guided AccuBoost partial breast irradiation procedure is offered either for breast boost therapy, as part of the course of whole-breast irradiation regimen or as a noninvasive monotherapy option for Accelerated Partial Breast Irradiation.

To learn more about breast brachytherapy, click here.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.